Sadra Medical Raises $30 Million

Sadra Medical, a Campbell, Calif.-based developer of therapies to treat aortic valve disease, has raised $30 million in Series C funding. Accuitive Medical Ventures led the round, and was joined by return backers Boston Scientific, Finistere, Firstmark Capital, Oakwood, ONSET Ventures, and SV Life Sciences.

8 May 2009•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail